Moreover, in HBV-related HCC the imbalance between inhibitory receptor NKG2A and activating receptor NKG2D on NK cells is associated with NK cell immunosuppression and tumor progression (43). The gene discussed is KLRK1; the disease is hepatocellular carcinoma.